Genus Power Infrastructures Limited (BOM:530343)

Inozyme Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	7,600	1,608	599.4	104.93	640.61
Short-Term Investments	-	1,723	3,343	876.61	523.85	228.6
Trading Asset Securities	-	-	1,861	2,246	2,128	1,683
Cash & Short-Term Investments	9,323	9,323	6,811	3,722	2,757	2,552
Cash Growth	8.85%	36.88%	83.00%	35.00%	8.04%	27.48%
Accounts Receivable	-	14,084	6,247	4,718	5,577	5,653
Other Receivables	-	-	146.76	63.93	84.64	75.73
Receivables	-	14,184	7,118	4,988	5,762	5,729
Inventory	-	8,496	4,831	2,859	2,201	1,779
Prepaid Expenses	-	-	697.11	217.52	4.17	4.97
Other Current Assets	-	2,479	2,953	1,135	651.83	515.9
Total Current Assets	-	34,483	22,410	12,922	11,376	10,581
Property, Plant & Equipment	-	3,225	2,065	1,629	1,560	1,611
Long-Term Investments	-	362.88	1,363	1,149	1,009	909.76
Other Intangible Assets	-	31.77	13.17	10.7	15.34	16.34
Long-Term Accounts Receivable	-	1,462	732.95	0.52	25.63	26.01
Long-Term Deferred Tax Assets	-	-	-	-	-	33.48
Other Long-Term Assets	-	2,330	575.08	498.44	871.04	219.19
Total Assets	-	43,459	27,669	16,620	15,121	13,657
Accounts Payable	-	5,796	3,668	1,639	1,924	1,660
Accrued Expenses	-	48.09	178.53	108.69	54.39	61.46
Short-Term Debt	-	-	4,557	2,323	2,618	1,870
Current Portion of Long-Term Debt	-	9,269	531.71	1,129	73.65	122.19
Current Portion of Leases	-	12.79	6.87	3.88	9.16	4.07
Current Income Taxes Payable	-	282.21	102.47	26.7	8.44	27.23
Current Unearned Revenue	-	285.49	684.28	406.66	114.2	99.86
Other Current Liabilities	-	1,821	154.03	123.19	230.88	203.08
Total Current Liabilities	-	17,515	9,883	5,760	5,033	4,048
Long-Term Debt	-	4,377	782.17	16.93	7.75	75.17
Long-Term Leases	-	-	1.39	1.71	1.21	0.46
Long-Term Unearned Revenue	-	1,316	695.18	634.29	33.81	38.95
Long-Term Deferred Tax Liabilities	-	356.46	34.32	11.75	29.31	-
Other Long-Term Liabilities	-	1,104	516.09	384.13	431.67	441.34
Total Liabilities	-	24,784	11,960	6,818	5,552	4,612
Common Stock	-	276.38	303.76	257.6	257.51	257.36
Additional Paid-In Capital	-	-	5,966	820.91	819.88	816.34
Retained Earnings	-	-	9,286	8,599	8,359	7,897
Treasury Stock	-	-	-27.54	-27.54	-27.54	-27.54
Comprehensive Income & Other	-	18,399	179.9	152.42	160.04	102.79
Shareholders' Equity	18,675	18,675	15,709	9,802	9,568	9,046
Total Liabilities & Equity	-	43,459	27,669	16,620	15,121	13,657
Total Debt	13,659	13,659	5,879	3,475	2,710	2,072
Net Cash (Debt)	-4,335	-4,335	931.68	247.25	47.15	479.72
Net Cash Growth	-	-	276.82%	424.42%	-90.17%	-
Net Cash Per Share	-15.58	-15.59	3.86	1.06	0.20	2.07
Filing Date Shares Outstanding	276.3	276.48	276.21	230.05	229.97	229.82
Total Common Shares Outstanding	276.3	276.48	276.21	230.05	229.97	229.82
Working Capital	-	16,968	12,527	7,162	6,343	6,533
Book Value Per Share	67.55	67.55	56.87	42.61	41.61	39.36
Tangible Book Value	18,644	18,644	15,696	9,791	9,553	9,029
Tangible Book Value Per Share	67.43	67.43	56.83	42.56	41.54	39.29
Land	-	-	60.04	60.04	60.04	60.04
Buildings	-	-	773.5	749.9	738.98	738.13
Machinery	-	-	2,213	1,741	1,595	1,506
Construction In Progress	-	-	146.28	72.75	19.84	0.84
Order Backlog	-	301,100	210,000	-	-	-

Updated Feb 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.